We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms.
- Authors
Guardiola, Salvador; Varese, Monica; Sánchez‐navarro, Macarena; Vincke, Cécile; Teixidó, Meritxell; García, Jesús; Muyldermans, Serge; Giralt, Ernest
- Abstract
One of the hallmarks of cancer is the overproduction of growth factors such as EGF. Despite the clinical success achieved by EGFR‐targeted therapies, their long‐term efficacy is compromised by the onset of drug‐resistant mutations. To address this issue, a family of camelid‐derived single‐domain antibodies (Nbs) were generated, obtaining the first direct EGF inhibitors that prevent EGFR phosphorylation and pathway activation through this new mechanism of action. The two best Nbs were subjected to a detailed investigation of their interaction mechanism that revealed important differences in their binding kinetics and equilibrium thermodynamics. These distinct behaviors at the biophysical level translate into an equally efficient inhibition of the cellular EGFR phosphorylation, thus proving the efficacy of these Nbs to turn off the initiation of this key oncogenic pathway in cancer cells.
- Subjects
EPIDERMAL growth factor receptor genetics; MULTIDRUG resistance in bacteria; BACTERIAL mutation; DELETION mutation; CAMELIDAE; PHOSPHORYLATION kinetics; MOLECULAR recognition
- Publication
Angewandte Chemie, 2018, Vol 130, Issue 42, p14039
- ISSN
0044-8249
- Publication type
Article
- DOI
10.1002/ange.201807736